Abstract
A direct spectrophotometric method for the determination of Entecavir is developed. Entecavir is a guanine analogue that is used in the treatment of hepatitis B. The absorbance of the pure drug was measured at wavelength 253 nm. The method was found linear from 2.5-40 μg mL-1 (r2, 0.999). The RSD was 1.1% and accuracy was 99%. The validation results and statistical data demonstrate that the method is reliable, simple, cost effective and reproducible and has an importance in quality assurance of Entecavir analysis.
| Original language | English |
|---|---|
| Pages (from-to) | 1605-1608 |
| Number of pages | 4 |
| Journal | Journal of the Chemical Society of Pakistan |
| Volume | 34 |
| Issue number | 6 |
| State | Published - Dec 2012 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Entecavir
- Spectrophotometer
- Tablet dosage form
ASJC Scopus subject areas
- General Chemistry
Fingerprint
Dive into the research topics of 'Development and validation of a spectrophotometric method for the determination of entecavir in pure and tablet dosage form'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver